BRNS
Price
$0.74
Change
-$0.02 (-2.63%)
Updated
Sep 8 closing price
Capitalization
30.23M
34 days until earnings call
Intraday BUY SELL Signals
NEUP
Price
$3.47
Change
-$0.04 (-1.14%)
Updated
Oct 2, 04:54 PM (EDT)
Capitalization
19.75M
Intraday BUY SELL Signals
Interact to see
Advertisement

BRNS vs NEUP

BRNS vs NEUP Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BRNS vs. NEUP commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRNS is a StrongBuy and NEUP is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
TECHNICAL ANALYSIS
Technical Analysis
BRNSNEUP
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
N/A
Bullish Trend 11 days ago
89%
Declines
ODDS (%)
Bearish Trend 30 days ago
88%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
84%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (BRNS: $0.74 vs. NEUP: $3.51)
Brand notoriety: BRNS and NEUP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRNS: 210% vs. NEUP: 27%
Market capitalization -- BRNS: $30.23M vs. NEUP: $19.75M
BRNS [@Biotechnology] is valued at $30.23M. NEUP’s [@Biotechnology] market capitalization is $19.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRNS’s FA Score shows that 1 FA rating(s) are green while NEUP’s FA Score has 2 green FA rating(s).

  • BRNS’s FA Score: 1 green, 4 red.
  • NEUP’s FA Score: 2 green, 3 red.
According to our system of comparison, NEUP is a better buy in the long-term than BRNS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRNS’s TA Score shows that 4 TA indicator(s) are bullish while NEUP’s TA Score has 4 bullish TA indicator(s).

  • BRNS’s TA Score: 4 bullish, 4 bearish.
  • NEUP’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BRNS is a better buy in the short-term than NEUP.

Price Growth

BRNS (@Biotechnology) experienced а 0.00% price change this week, while NEUP (@Biotechnology) price change was -4.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.58%. For the same industry, the average monthly price growth was -14.40%, and the average quarterly price growth was -1.79%.

Reported Earning Dates

BRNS is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-3.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
BRNS
Daily Signal:
Gain/Loss:
NEUP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MMI28.960.51
+1.79%
Marcus & Millichap
DYOR10.15N/A
N/A
Insight Digital Partners II
WH71.49-0.35
-0.49%
Wyndham Hotels & Resorts
KSCP0.76-0.01
-1.91%
Knightscope Inc
BCS23.64-0.63
-2.60%
Barclays PLC

BRNS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRNS has been loosely correlated with NGNE. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if BRNS jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRNS
1D Price
Change %
BRNS100%
N/A
NGNE - BRNS
51%
Loosely correlated
-4.57%
NEUP - BRNS
50%
Loosely correlated
-1.40%
TARA - BRNS
35%
Loosely correlated
-9.51%
BGMS - BRNS
31%
Poorly correlated
+2.52%
ARGX - BRNS
29%
Poorly correlated
-2.39%
More

NEUP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEUP has been loosely correlated with BRNS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if NEUP jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEUP
1D Price
Change %
NEUP100%
-1.40%
BRNS - NEUP
50%
Loosely correlated
N/A
SLGL - NEUP
36%
Loosely correlated
-1.72%
LKFT - NEUP
32%
Poorly correlated
-2.66%
ENSC - NEUP
31%
Poorly correlated
-3.85%
INBX - NEUP
28%
Poorly correlated
-2.15%
More